In general, proper regulation of AMPK, SIRT1, and mTOR activities—especially enhancing AMPK and SIRT1 function while inhibiting mTOR signaling—could help restore or enhance autophagic activity, potentially mitigating the pathological changes associated with DKD. The gene discussed is MTOR; the disease is diabetic kidney disease.